EUVIMEDObjevte EUVIMED
Open access · CC BY-NC 4.0

Prothrombotic Activation of Platelet Pannexin‐1 Channels in Antiphospholipid Syndrome

Bruna de Moraes Mazetto Fonseca iD, Somanathapura K NaveenKumar iD, Srilakshmi Yalavarthi, Kavya Sugur, Thalia G Newman, Claire K Hoy, Cyrus Sarosh, Jordan K Schaefer, Ajay Tambralli, Jacqueline A Madison, Yu Zuo iD, Fernanda A Orsi iD and 2 more

Arthritis & Rheumatology · 2026

DOI: 10.1002/art.70001 ↗

At a glance

Journal article in Arthritis & Rheumatology, 2026. Written by Bruna de Moraes Mazetto Fonseca and 13 co-authors. Institution: Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor. Major MEDLINE topics: Connexins, Antiphospholipid Syndrome, Nerve Tissue Proteins, Blood Platelets. 15 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIAMS NIH HHS, NIH HHS, Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

ATP is released from platelets through both degranulation and pannexin‐1 (PANX1) channels. ATP then activates P2X receptors to amplify platelet activation via calcium‐dependent signaling. The objective of this study was to evaluate the role of platelet PANX1 channels in the pathophysiology of antiphospholipid syndrome (APS), an acquired thromboinflammatory disorder characterized by platelet‐activating antiphospholipid antibodies.

Methods

Extracellular ATP release was measured in platelets isolated from patients with persistently positive antiphospholipid antibodies (n = 36), patients with systemic lupus erythematosus (n = 10), and healthy controls (n = 16). In some assays, purified platelets were pretreated with the PANX inhibitor carbenoxolone. Platelet signaling, P‐selectin exposure, and aggregation were assessed.

Results

Basal ATP release was significantly higher in APS platelets than in controls ( P < 0.0001) and normalized in the presence of carbenoxolone ( P = 0.03). Carbenoxolone also reduced platelet ATP release and surface P‐selectin expression induced by thrombin ( P = 0.002 and P = 0.02, respectively) and convulxin ( P = 0.0001 and P = 0.0012). Control platelets stimulated with IgG from patients with APS demonstrated enhanced phosphorylation of PANX1 at tyrosine‐308 ( P = 0.03), which was accompanied by enhanced ATP release ( P = 0.0004). APS IgG boosted ADP‐induced aggregation ( P = 0.0011), which was reduced by carbenoxolone ( P = 0.0007). The calcium chelator BAPTA‐AM decreased APS IgG–mediated ATP release ( P = 0.03), P‐selectin expression ( P = 0.0005), and aggregation ( P = 0.0007). Desensitizing P2X1 receptors with α,β‐MeATP decreased APS IgG–induced P‐selectin expression ( P = 0.0002) and aggregation ( P = 0.01).

Conclusion

PANX1 channels appear to be important mediators of platelet activation in APS. Agents that block PANX1 may restore platelet homeostasis and limit thrombosis without impairing hemostasis. image

Subjects

MeSH terms (MEDLINE)

ConnexinsAntiphospholipid SyndromeNerve Tissue ProteinsBlood PlateletsPlatelet ActivationThrombosisHumansAdenosine TriphosphateFemaleMaleP-SelectinAdultMiddle AgedCarbenoxolonePlatelet AggregationCase-Control Studies

Substances

ConnexinsPANX1 protein, humanAdenosine TriphosphateNerve Tissue ProteinsP-SelectinCarbenoxolone

Authors and institutions

  • Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor.
  • School of Medical Sciences, University of Campinas, Campinas, Brazil.
  • Division of Hematology, Department of Internal Medicine, University of Michigan, Ann Arbor.
  • Department of Pathology, School of Medical Sciences, University of Campinas, Campinas, Brazil.
  • Department of Pharmacology, University of Michigan Medical School, Ann Arbor.

ORCID profiles: Bruna de Moraes Mazetto Fonseca, Somanathapura K NaveenKumar, Yu Zuo, Fernanda A Orsi, Jason S Knight

Funding

  • NIAMS NIH HHS
  • NIH HHS
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • NHLBI NIH HHS
  • Rheumatology Research Foundation
  • Arthritis National Research Foundation
  • National Institutes of Health

Cite

APA

de Moraes Mazetto Fonseca, B., NaveenKumar, S. K., Yalavarthi, S., Sugur, K., Newman, T. G., Hoy, C. K., Sarosh, C., Schaefer, J. K., Tambralli, A., Madison, J. A., Zuo, Y., Orsi, F. A., Holinstat, M., & Knight, J. S. (2026). Prothrombotic Activation of Platelet Pannexin‐1 Channels in Antiphospholipid Syndrome. Arthritis & Rheumatology. https://doi.org/10.1002/art.70001

Vancouver

de Moraes Mazetto Fonseca B, NaveenKumar SK, Yalavarthi S, Sugur K, Newman TG, Hoy CK, et al. Prothrombotic Activation of Platelet Pannexin‐1 Channels in Antiphospholipid Syndrome. Arthritis & Rheumatology. 2026. doi:10.1002/art.70001

BibTeX
@article{deMoraesMazettoFonseca2026,
  author = {de Moraes Mazetto Fonseca, Bruna and NaveenKumar, Somanathapura K and Yalavarthi, Srilakshmi and Sugur, Kavya and Newman, Thalia G and Hoy, Claire K and Sarosh, Cyrus and Schaefer, Jordan K and Tambralli, Ajay and Madison, Jacqueline A and Zuo, Yu and Orsi, Fernanda A and Holinstat, Michael and Knight, Jason S},
  title = {Prothrombotic Activation of Platelet Pannexin‐1 Channels in Antiphospholipid Syndrome},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70001}
}
Start for free →